Advertisement

Journal of Endocrinological Investigation

, Volume 26, Issue 6, pp 516–521 | Cite as

Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines

  • J. M. Cerutti
  • K. N. Ebina
  • S. E. Matsuo
  • L. Martins
  • R. M. B. Maciel
  • E. T. Kimura
Original Article

Abstract

Smad proteins have been shown to mediate the signal transduction pathway downstream of the transforming growth factor β (TGFβ). TGFβ induces the phosphorylation of Smad2 and Smad3 which associate with Smad4 and translocate to the nucleus where they regulate gene transcription; besides these stimulatory Smads, the inhibitory Smads, Smad6 and Smad7, oppose signaling by blocking receptors and interrupting the phosphorylation of Smads2/3. The loss of TGFβ-sensitivity, caused by inactivation of components of TGFβ signaling, as Smad4, underlies a wide variety of human disorders, including cancer. In addition, the overexpression of the inhibitory Smad7, which prevents the phosphorylation of Smad2/3 and consequently inhibits TGFβ signaling pathways, was observed in some diseases. In the present study we investigated the expression of Smad4 and Smad7 in thyroid cell lines (NPA papillary carcinoma, WRO follicular carcinoma and ARO anaplastic carcinoma) by RT-PCR and immunocytochemistry. Our results show that Smad4 was expressed in all thyroid cell lines and controls analyzed, differently from other classes of tumors where Smad4 expression was deleted. On the other hand, Smad7 was overexpressed in ARO anaplastic cell line, the most malignant follicular thyroid carcinoma. Our data suggest that the abrogation of the TGFβ response by Smad7 overexpression may be a mechanism for the tumor aggressiveness observed in undifferentiated thyroid tumors.

Key-words

Smad7 Smad4 TGFβ signaling thyroid carcinoma cell line 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Heldin C.H., Miyazono K., ten Dijke P. TGF-β signaling from cell membrane to nucleus through Smad proteins. Nature 1997, 390: 465–471.PubMedCrossRefGoogle Scholar
  2. 2.
    Massagué J., Blain S.W., Lo R.S. TGF β signaling in growth control, cancer, and heritable disorders. Cell 2000, 103: 295–309.PubMedCrossRefGoogle Scholar
  3. 3.
    Blobe C.G, Schieldmann W.P, Lodish H.F. Role of transforming growth factor β in human disease. N. Engl. J. Med. 2000, 342: 1350–1358.PubMedCrossRefGoogle Scholar
  4. 4.
    Wrana J.L. Regulation of Smad activity. Cell 2000, 100: 189–192.PubMedCrossRefGoogle Scholar
  5. 5.
    Attisano L., Lee-Hoeflich S.T. The Smads. Genome Biology 2001, 2: 3010.1–3010.8.CrossRefGoogle Scholar
  6. 6.
    Nakao A., Afrakhte M., Morén A., et al. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 1997, 389: 631–635.PubMedCrossRefGoogle Scholar
  7. 7.
    Hölting T., Zielke A., Siperstein A.E., Clark O.H., Duh Q-Y. Transforming growth factor-β1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines. J. Clin. Endocrinol. Metab. 1995, 79: 806–813.Google Scholar
  8. 8.
    Markowitz S., Wang J., Myeroff L., et al. Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 1995, 268: 1336–1338.PubMedCrossRefGoogle Scholar
  9. 9.
    Hahn S.A., Schutte M., Hoque A.T.M.S., et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996, 271: 350–353.PubMedCrossRefGoogle Scholar
  10. 10.
    Riggins G.J., Kinzler K.W., Vogelstein B., Thiagalingam S. Frequency of Smad mutations in human cancers. Cancer Res. 1997, 57: 2578–2580.PubMedGoogle Scholar
  11. 11.
    Kimura E.T., Kopp P., Zbaeren J., et al. Expression of transforming growth factor β1, β2, and β3 in multinodular goiters and differentiated thyroid carcinomas: a comparative study. Thyroid 1999, 9: 119–125.PubMedCrossRefGoogle Scholar
  12. 12.
    Ohta K., Pang X.P., Berg L., Hershman J.M. Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines. J. Clin. Endocrinol. Metab. 1996, 81: 2607–2612.PubMedGoogle Scholar
  13. 13.
    Asmis L.M., Kaempf J., Von Gruenigen C., Kimura E.T., Wagner H.E., Studer H. Acquired and naturally occurring resistance of thyroid follicular cells to the growth inhibitory action of transforming growth factor-beta 1 (TGF-β1). J. Endocrinol. 1996, 149: 485–496.PubMedCrossRefGoogle Scholar
  14. 14.
    Estour A.J., Van Herle G.J.F., Juillard T.L., et al. Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch. [Cell. Pathol.] 1989, 57: 167–174.CrossRefGoogle Scholar
  15. 15.
    Pang X.J., Hershmann J.M., Chung M., Pekary A.E. Characterization of tumor necrosis factor-a receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology 1989, 125: 1783–1788.PubMedCrossRefGoogle Scholar
  16. 16.
    Biscolla R.P.M., Cerutti J.M., Maciel R.M.B. Detection of recurrent thyroid cancer by sensitive nested RT-PCR of thyroglobulin and sodium/iodine symporter messenger RNA transcripts in peripheral blood. J. Clin. Endocrinol. Metabol. 2000, 85: 3623–3627.Google Scholar
  17. 17.
    Park K., Kim S.J., Bang Y., Park J.K., Roberts A.B., Sporn M.P. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA 1994, 91: 8772–8776.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Cowin A.J., Davis J.R.E., Bidey S.P. Transforming growth factor-β1 production in porcine thyroid follicular cells: regulation by intrathyroidal organic iodine. J. Mol. Endocrinol. 1992, 9: 197–205.PubMedCrossRefGoogle Scholar
  19. 19.
    Grubeck-Loebenstein B., Buchan G., Sadeghi R. et al. Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter. J. Clin. Invest. 1989, 83: 764–770.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Lazzareschi D., Ranieri A., Mincione G., Taccogna S., Nardi F., Colleta G. Human malignant thyroid tumors displayed reduced levels of transforming growth factor β receptor type II messenger RNA and protein. Cancer Res. 1997, 57: 2071–2076.Google Scholar
  21. 21.
    West J., Munoz-Antonia T., Johnson J.G., Klotch D., Muro-Cacho C.A. Transforming growth factor-β type II receptors and Smad proteins in follicular thyroid tumors. Laryngoscope 2000, 110: 1323–1327.PubMedCrossRefGoogle Scholar
  22. 22.
    Heldin N.E., Bergström D., Hermansson A., et al. Lack of responsiveness to TGF-β1 in a thyroid carcinoma cell line with functional type I and type II TGF-β receptors and Smad proteins, suggests a novel mechanism for TGF-β insensitivity in carcinoma cells. Mol. Cell. Endocrinol. 1999, 153: 79–90.PubMedCrossRefGoogle Scholar
  23. 23.
    Chen C-H., Kang Y., Massagué J. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program. Proc. Natl. Acad. Sci. USA 2001, 98: 992–999.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Pientepol J.A., Münger K., Howley P.M., Stein R.W., Moses H.L. Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor β1 and by the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 1991, 88: 10227–10231.CrossRefGoogle Scholar
  25. 25.
    Usa T., Tsukazaki T., Namba H., et al. Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-β1 in thyroid carcinoma cell growth. Endocrinology 1994, 135: 1378–1384.PubMedGoogle Scholar
  26. 26.
    Cerutti J.M., Trapasso F., Battaglia C., et al. Block of cmyc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines. Clin. Cancer Res. 1996, 2: 119–126.PubMedGoogle Scholar
  27. 27.
    Visconti R., Cerutti J.M., Battista S., et al. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκβ p65 protein expression. Oncogene 1997, 15: 1987–1994.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2003

Authors and Affiliations

  • J. M. Cerutti
    • 1
  • K. N. Ebina
    • 2
  • S. E. Matsuo
    • 2
  • L. Martins
    • 2
  • R. M. B. Maciel
    • 1
  • E. T. Kimura
    • 2
  1. 1.Laboratory of Molecular Endocrinology, Division of Endocrinology, Department of MedicineUniversidade Federal de São PauloSão PauloBrazil
  2. 2.Department of Histology and Embryology, Institute of Biomedical SciencesUniversidade de São PauloSão PauloBrazil

Personalised recommendations